Scientists Discover New Human Organ
Researchers from New York University’s School of Medicine say that they have discovered a new organ that has been hiding in plain sight. The study, recently published in Scientific Reports, shows that the organ, which …
Spark Therapeutics Shares Plunged More Than 40% Today, Here’s Why
On Monday, in early trade, Spark Therapeutics, Inc. (NASDAQ:ONCE) saw its shares plunge more than 40%.
What happened? Well, the decline started after the gene therapy biotech company disclosed data from various trials …
CVS to Purchase Healthcare Insurance Company Aetna
Breaking news: drugstore chain CVS Health (NYSE:CVS) is purchasing healthcare insurance behemoth Aetna (NYSE:AET).
If the proposed deal, which was announced Sunday, is approved, the $69 billion acquisition would wholeheartedly revamp the healthcare …
Teva Pharmaceutical Industries Reportedly to Fire 1,700 Workers in Coming Months
It has been reported that Teva Pharmaceutical Industries (NYSE:$TEVA) is forecasted to fire roughly 1,700 workers in the coming months as part of the Israeli drug manufacturer’s streamlining plan that aims at hitting back at …
U.S. Regulators Approve Digital Pill That Tracks When People Take It
That’s one small step for man, one giant leap for healthcare and technology. On Tuesday, the FDA announced that it has approved the first digital pill that has a sensor to track if patients are …
Teva Pharmaceutical Reports Drop in Q3 Profit, Shares Plunge Almost 18%
Now might not be the time to get into the drug manufacturers industry. Well, maybe just don’t invest in Teva Pharmaceutical Industries (NYSE:$TEVA) for the time being.
On Thursday, after Teva Pharmaceutical – …
Pfizer Inc. Developing 15 New Drugs That Could Be Approved For Sale By 2020
Pharmaceutical company Pfizer Inc. (NYSE:$PFE) saw its revenue increase in its latest quarter as the drug manufacturer says it forecasts more product launches in the next several years combined with fewer drug-exclusivity losses.
…
3 Reasons Behind Celgene Corp.’s Abysmal Q3 Earnings Report
On Thursday, Celgene Corp. (NASDAQ:$CELG) reported its Q3 earnings report- and let’s just say it did not go nearly as well as we hoped. Missing revenue by a whopping $120 million, Celgene has since plummeted …
California Judge Throws Out $417M Cancer Verdict Against Johnson & Johnson
Have you heard the latest in the drug manufacturers industry? A California judge on Friday, October 20, threw out a $417 million verdict against pharmaceutical company Johnson & Johnson (NYSE:$JNJ) in a lawsuit by a …
Celgene Abandons Crohn’s Drug, Shares Drop to Four-Month Low
As of this morning, Celgene (NASDAQ:$CELG) shares have dropped to a four-month low, following scrapped trials in Crohn’s disease.
Celgene shares plunged as much as 10.9%, near 122.40. Shares hit a low last …